col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


347 Results       Page 1

 [1] 
Oxford University Press: European Heart Journal
  original article Date Title Authors   All Authors
1 [GO] 2023―Jan―25 Cardiovascular profile and electrocardiographic findings of hospitalized adult patients during the surge of delta and omicron variants of COVID-19 in a COVID-19 tertiary referral center P A O Alad, F E R Punzalan, E J B Llanes, J A M Aherrera, G G Gervacio, E B Reyes, J C Anonuevo
2 [GO] 2023―Jan―25 Cardiac rehabilitation results among patients who have undergone cardiac surgery after covid-19 infection N Lampus, T Ransun, A M Ambari, B Dwiputra, B Radi
3 [GO] 2023―Jan―25 An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection M Manalili, J Dionisio
4 [GO] 2023―Jan―25 Cardiovascular Profile of patients with COVID-19 infection admitted at a tertiary hospital R Tugade, E Ongjoco, M Turalba, A Yabon, N Bisquera, L Gonzales, et al. (+3)
5 [GO] 2023―Jan―25 Incidence of myocarditis among patients recovered from COVID-19 infection identified using cardiac magnetic resonance imaging R Tugade, N Palileo, A Panelo, M Correa, D Leycano, C Pawhay, J Cosare-San Pedro
6 [GO] 2023―Jan―25 Vaccination status and knowledge of CPR do not affect medical students' decision to perform BLS during the COVID-19 pandemic A P Bantolo, R G A Naranjilla
7 [GO] 2023―Jan―25 Modified STEMI protocol for Primary PCI during COVID-19 Pandemic:Does it prolong Door-To-Balloon performance? A Y Putranto, T M Haykal Putra, W A Soedarsono
8 [GO] 2023―Jan―25 Arterial thromboembolism (ATE) and mortality among COVID-19 patients in the intensive care unit (ICU): prevalence and risk factors H Zulkifly, F Mansor, I Abdul Halim Zaki, L C Kiok, T Ravi, M Pathmanathan
9 [GO] 2023―Jan―25 Electrocardiographic predictors of disease severity, mortality, and advanced ventilatory support among hospitalized covid-19 patients: a two year single center retrospective, cohort study G Vista, M Vestal
10 [GO] 2023―Jan―25 Pathophysiologic mechanism for MYOcarditis in COVID-19 VAccinations ("MYOVAx" Study) J Y Tan, Y W Chia, M Chan, S L Lim, C Chin, J Yap, et al. (+9)
11 [GO] 2023―Jan―25 Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2 M J Makhyan Jibril Al Farabi, H O Hanestya Oky Hermawan, P M H Primasitha Maharani Harsoyo, S G D Stavros George Drakos, I G R I Gde Rurus Suryawan, M A Meity Ardiana
12 [GO] 2023―Jan―25 Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic K K K Kyaw, I B Menown
13 [GO] 2023―Jan―25 Improving cardiovascular health behaviors through a comprehensive lifestyle intervention program during the pandemic in India P Chockalingam, S Rajeswari, J Shobika, R Anantharaman, M M Yusuf, G Sengottuvelu, V Chockalingam
14 [GO] 2022―Oct―15 Autoantibodies against the cardiovascular protective BPIFB4 in hospitalized patients with COVID-19 E Ciaglia, F Montella, V Lopardo, R M Esposito, F Guarracino, G Spinetti, et al. (+8)
15 [GO] 2022―Oct―15 The role of cardiac troponin-I as a prognostic tool for mortality in patients hospitalized with COVID-19 J Quintal, A P Candjondjo, R A Coelho, A R Piteira, J S Simoes, R Pereira, et al. (+9)
16 [GO] 2022―Oct―15 The state of systolic and diastolic functions of the left ventricle and heart rate variability in patients with atrial fibrillation after infection of COVID-19 O S Sychov, O G Nesukay, O V Stasyshena, T V Getman, O V Sribna, O M Romanova, et al. (+2)
17 [GO] 2022―Oct―15 Impaired heart rate variability one and six months post acute COVID-19 S Lampsas, E Oikonomou, N Souvaliotis, A Goliopoulou, G A Papamikroulis, A Anastasiou, et al. (+9)
18 [GO] 2022―Oct―15 Incidence of atrial and ventricular arrhythmias in patients with CIEDs and COVID-19 A D Margulescu, D E Thomas, M Kakoudaki, H Cranch, J O'Dea, G Davies, et al. (+4)
19 [GO] 2022―Oct―15 The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19 R R Bruno, B Wernly, G Wolff, A Artigas, B B Pinto, J C Schefold, et al. (+9)
20 [GO] 2022―Oct―15 Time-related aortic inflammatory response, as assessed with 18F-FDG PET/CT, in patients hospitalized with severely or critical COVID-19 E Solomou, D Terentes-Printzios, V Gardikioti, P Katsaounou, D Exarchos, D Economou, et al. (+9)
21 [GO] 2022―Oct―15 Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19 D Keshwani, C Eyileten, Z Wicik, A Nowak, D Jakubik, S N Simoes, et al. (+6)
22 [GO] 2022―Oct―15 Protective effects of COVID-19 vaccination on endothelial function of patients with COVID-19 S Lampsas, E Oikonomou, N Souvaliotis, G A Papamikroulis, T Lytra, S Sarantos, et al. (+9)
23 [GO] 2022―Oct―15 Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19 R Batta, G Tornling, E Rosendahl, T Bengtsson, J Raud
24 [GO] 2022―Oct―15 Galectin-3 as a possible marker for increased thrombogenicity in COVID-19 M Puccini, K Jakobs, J Friebel, L Reinshagen, P A Schencke, A Haghikia, et al. (+3)
25 [GO] 2022―Oct―15 Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19 K Jakobs, M Puccini, L Reinshagen, A A Alsheikh, J Friebel, U Lanmdesser, et al. (+3)
26 [GO] 2022―Oct―15 Predictors and clinical consequences of heart damage in CMR in patients after COVID-19 M Chudzik, D Miskowiec, J Kapusta, M Babicki, J D Kasprzak
27 [GO] 2022―Oct―15 The use of handheld ultrasound device in cardiac examination of patients with history of COVID-19 D Filipiak, J D Kasprzak, P Lipiec
28 [GO] 2022―Oct―15 The role of cardiometabolic risk factors and endothelial dysfunction in serum albumin levels and capillary leak syndrome of patients with COVID-19 E Oikonomou, S Lampsas, V Lampadiari, E Korakas, E Bletsa, N Souvaliotis, et al. (+9)
29 [GO] 2022―Oct―15 Adults with congenital heart disease and COVID-19 N Langes, S J Maurer, C Meierhofer, N Nagdyman, F Bourier, S Holdenrieder, et al. (+2)
30 [GO] 2022―Oct―15 Cardiac injury before and after COVID-19. A longitudinal MRI study J E Gonzalez, A Doltra, R J Perea, P Lapena, C Garcia-Ribas, J Reventos, et al. (+9)
31 [GO] 2022―Oct―15 Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis P Jirak, V Van Almsick, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, et al. (+9)
32 [GO] 2022―Oct―15 COVID-19 and acute heart failure among patients with cancer M Bergami, N Fabin, P Mjehovic, M Pasalic, M Scarpone, Z Vasiljevic, et al. (+9)
33 [GO] 2022―Oct―15 COVID-19 and cardiovascular system: not only heart but also vascular. The effects of the infection on arterial stiffness A Maloberti, E Gualini, S Scarpellini, M Algeri, M Biolcati, E Grasso, et al. (+2)
34 [GO] 2022―Oct―15 D-dimer-driven versus standard prophylactic anticoagulation with fondaparinux in critically ill patients with COVID-19 and coagulopathy: an open-label, randomized controlled trial L H Adrian, S A Hutomo, A D S Negari
35 [GO] 2022―Oct―15 Variables associated with bleeding and thrombotic outcomes among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomised clinical trial P G Barros E Silva, R D Lopes, R H M Furtado, A V S Macedo, B Bronhara, L P Damiani, et al. (+9)
36 [GO] 2022―Oct―15 COVID-19 and the autonomic nervous system R A Xuereb, R G Xuereb, C Barbara, S Fava, C J Magri
37 [GO] 2022―Oct―15 COVID-19 associated Brugada pattern electrocardiogram: systematic review of case reports K C Chen, A Z Rathore, T Deol, K L Liu, E W Wu, J S Su, et al. (+2)
38 [GO] 2022―Oct―15 Post COVID-19 cardiac magnetic resonance findings among inpatients vs outpatients M Klinceva, L V Veljanovska-Kiridzievska, P Z Zafirovska, E I Idoski, V A Ampova-Sokolov, T A Angjusheva, et al. (+4)
39 [GO] 2022―Oct―15 Atherosclerosis licenses for an exceeding immune response in COVID-19 disease J Leberzammer, W T Abplanalp, S F Glaser, B Schumacher, M Merten, M T Katschke, et al. (+5)
40 [GO] 2022―Oct―15 Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation J Jarosz-Popek, C Eyileten, Z Wicik, A Nowak, M Wolska, A Shahzadi, et al. (+5)
41 [GO] 2022―Oct―15 History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden V Ritsinger, J Bodegard, R Kristofi, M Thuresson, D Nathanson, T Nystrom, et al. (+2)
42 [GO] 2022―Oct―15 The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era I Ikonomidis, K Katogiannis, K Kourea, G Kostelli, D Tsilivarakis, G Pavlidis, et al. (+6)
43 [GO] 2022―Oct―15 Cardiovascular features and risk of mortality in COVID-19 hospitalized patients in Spain during 2020. A nationwide study from the Minimum Basic Data Set C Risco Risco, L Ayerbe Garcia-Monzon, P Villares Fernandez, A Martin Arnau, D Andaluz Ojeda
44 [GO] 2022―Oct―15 Trends and risk factors of in-hospital mortality of patients with COVID-19 in Germany K Keller, I Sagoschen, S Barco, I Schmidtmann, C Espinola-Klein, S Konstantinides, et al. (+2)
45 [GO] 2022―Oct―15 Cardiopulmonary long-term effects in patients after hospitalization due to COVID-19 infection J Niebauer, C Binder, A Iscel, S Klenk, C Capelle, M Kahr, et al. (+9)
46 [GO] 2022―Oct―15 Anxiety and depression among ambulatory and hospitalized patients with cardiovascular long-COVID-19 presentation referred to cardiology consultation after COVID-19 infection P Rasmus, J D Kasprzak, M Chudzik, A Lipert
47 [GO] 2022―Oct―15 COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism L Hobohm, I Sagoschen, S Barco, I Farmakis, U Fedeli, S Koelmel, et al. (+5)
48 [GO] 2022―Oct―15 Coronary microvascular health in patients with prior COVID-19 infection and no known CAD A I Ahmed, J M Saad, Y Han, F Alahdab, M Malahfji, F Nabi, et al. (+4)
49 [GO] 2022―Oct―15 Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months I Ikonomidis, A Kountouri, A Mitrakou, K Katogiannis, J Thymis, E Korakas, et al. (+8)
50 [GO] 2022―Oct―15 Prevalence and diagnostic significance of novel 12-lead ECG patterns following COVID-19 infection in elite soccer players R Bhatia, A Malhotra, H MacLachlan, S Gati, A Kasiakogias, S Marwaha, et al. (+9)
51 [GO] 2022―Oct―15 Effects of COVID-19 infection on ECG parameters in outpatients H Deniz, F Deniz
52 [GO] 2022―Oct―15 Assessment of cardiac involvement in patients recovered from corona virus disease-19 (COVID-19) infection using magnetic resonance imaging M Florentino, S Javier, S Sawit, V Geron, J De La Rosa, P Quetua, N Rosas
53 [GO] 2022―Oct―15 Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals M H Lassen, D Modin, K G Skaarup, B Claggett, S D Solomon, M Fralick, et al. (+9)
54 [GO] 2022―Oct―15 Effects of lockdown on physical activity and arrhythmia burden in patients with an implantable cardioverter-defibrillator: the COVID-19 Lockdown ICD-Carelink (CLIC) study M A Ghossein, D Linz, D J W Van Kraaij, A M W Van Stipdonk, M De Melis, K Vernooy, J Heijman
55 [GO] 2022―Oct―15 Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality M Mohamed, A Banerjee, S Clarke, M De Belder, A Goodwin, C Gale, et al. (+2)
56 [GO] 2022―Oct―15 Impact of COVID-19 on mechanical complications in ST elevation myocardial infarction N El Ouaddi, C Escabia, F Rueda, T Oliveras, S Montero, C Labata, et al. (+3)
57 [GO] 2022―Oct―15 The effect of COVID-19 on training in cardiology: a survey of UK cardiology trainees C J F Camm, A R Chapman, T R Gilpin, M Westwood, J P Greenwood, A Calver, C J Allen
58 [GO] 2022―Oct―15 ECG abnormalities and their relation to COVID-19 outcomes - a WHF study M Martins Pinto Filho, G M M Paixao, C P M Soares, P R Gomes, L Raspail, V Rossi, et al. (+5)
59 [GO] 2022―Oct―15 Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic E Alfonso Rodriguez, G Lopez Cabrera, L L Llerena Rojas, L Rodriguez Nande, L Lopez Ferrero, J Echarte Martinez
60 [GO] 2022―Oct―15 Aggression, mini-aggression, and abuse against health care workers during the COVID-19 pandemic S Garcia-Zamora, L Pulido, M Antoniolli, D Garcia, G Perez, M Priotti, et al. (+9)
61 [GO] 2022―Oct―15 Investigating monotherapy and combination therapy trends in newly diagnosed patients with pulmonary arterial hypertension among EU3 & UK physicians over the COVID-19 pandemic D Chandler, N Syarmimi, L Gill, N Allie
62 [GO] 2022―Oct―15 COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany V Oettinger, A Heidenreich, M Zehender, C Bode, P Stachon, K Kaier, C Von Zur Muehlen
63 [GO] 2022―Oct―15 A blueprint for the continuation of comprehensive cardiac rehabilitation during the COVID-19 pandemic. An Australian single hospital experience R Zecchin, C Dickson, J Hungerford, J Leow, G Lindsay, R Mander, et al. (+2)
64 [GO] 2022―Oct―15 COVID-19 pandemic and cardiovascular mortality and morbidity in the Czech Republic J Bruthans, J Rychtarikova, J Jarkovsky
65 [GO] 2022―Oct―15 Women in cardiology leadership of randomized clinical trials and participation of women in late-breaking clinical trials: has the COVID-19 pandemic changed a thing or not exactly? B Parapid, H Hachemi, F A Cader, M Alasnag, M Asanin, J Siller-Matula, et al. (+9)
66 [GO] 2022―Oct―15 Effects of the COVID-19 pandemic on offering and acceptance in a cardiac rehabilitation programme: introduction of a remote CR programme M Sestayo Fernandez, M Alonso Vazquez, A Gonzalez Maestro, V Gonzalez Salvado, J R Gonzalez Juanatey, C Pena Gil
67 [GO] 2022―Oct―15 Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction Z Motovska, O Hlinomaz, M Hromadka, P Kala, A Klechova, J Precek, et al. (+7)
68 [GO] 2022―Oct―15 Takostubo syndrome during the COVID-19 pandemic: a single center experience L Rallidis, D Iordanidis, N Kosmas, E Kiouri, K Papathanasiou, S Vlachos, G Filippatos
69 [GO] 2022―Oct―15 Mortality related to pulmonary embolism in the United States before and during the COVID-19 pandemic: an analysis of the CDC Multiple Cause of Death database I Farmakis, L Valerio, A C Mavromanoli, B Bikdeli, J M Connors, G Giannakoulas, et al. (+9)
70 [GO] 2022―Oct―15 Impact of COVID-19 pandemics upon nationwide pulmonary hypertension cohort: 18-months analysis of BNP-PL national database A Mamzer, J D Kasprzak, M Waligora, M Kurzyna, E Mroczek, T Mularek-Kubzdela, et al. (+9)
71 [GO] 2022―Oct―15 Evaluation of cardiovascular autonomic dysfunction in symptomatic post COVID-19 patients A M Noureldin, M Bassem, Z Abdelsalam
72 [GO] 2022―Oct―15 Admission serum magnesium levels associated with short- and long-term clinical outcomes in COVID-19 patients A Segev, A Sagir, S Matezky, A Segev, S Atar, M Shechter
73 [GO] 2022―Oct―15 Major adverse cardiac events in critically ill COVID-19 patients V Lopes, J P Baptista, N Moreira, L Goncalves
74 [GO] 2022―Oct―15 Impact of dexamethasone on cardiac injury in critically ill COVID-19 patients V Van Almsick, P Jirak, D Dimitroulis, M Mirna, C Seelmaier, Z Shomanova, et al. (+9)
75 [GO] 2022―Oct―15 Atrial fibrillation in COVID-19 patients admitted to an intensive care unit: prevalence and prognosis V Lopes, J P Baptista, N Moreira, L Goncalves
76 [GO] 2022―Oct―15 Specific characteristics of STEMI in COVID-19 patients and their practical implications: a systematic review M Gitto, L Novelli, O Cozzi, B Reimers, G Condorelli, G G Stefanini
77 [GO] 2022―Oct―15 Outcomes of COVID-19 patients with STEMI undergoing primary PCI P Kleczynski, L Niewiara, A Kulbat, M Kaczynski, T Pawlowski, S Socha`, et al. (+4)
78 [GO] 2022―Oct―15 Optimal thromboprophylaxis and anticoagulant strategies in patients with COVID-19 pneumonia. The PROTHROMCOVID Trial N Munoz-Rivas, J Aibar Gallizo, C Gabara-Xanco, A Trueba-Vicente, A Urbelz-Perez, V Gomez-Del Olmo, et al. (+9)
79 [GO] 2022―Oct―15 The effectiveness of a telemedical program for COVID-19 positive high-risk patients in domestic isolation L Brunelli, L Poelzl, J Hirsch, C Engler, F Naegele, T Egelseer-Bruendl, et al. (+7)
80 [GO] 2022―Oct―15 Comparison of thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction across the three waves of outbreak in the United Kingdom Z Teoh, K Rathod, A Tyrlis, F Choudry, K Comer, O Guttmann, et al. (+6)
81 [GO] 2022―Oct―15 Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry V Arevalos Rivas, L Ortega-Paz, D Fernandez-Rodriguez, V A Jimenez-Diaz, J Baneras Rius, G Campo, et al. (+9)
82 [GO] 2022―Oct―15 Long COVID-19 syndrome: association of cardiopulmonary impairment with a persistent platelet activation M Camera, M Brambilla, P Canzano, A Becchetti, M Conti, P G Agostoni, et al. (+6)
83 [GO] 2022―Oct―15 Blood pressure alterations in recently COVID-19 vaccinated patients E Sanidas, D Papadopoulos, T Anastasiou, M Velliou, E Michalaki, A Fotsali, et al. (+3)
84 [GO] 2022―Oct―15 COVID-19 vaccination in adults with congenital heart disease: results of 1-year prospective study A S Roma, F Fusco, G Papaccioli, M Abbate, G Scognamiglio, A Merola, et al. (+8)
85 [GO] 2022―Oct―15 Risk of worsening heart failure and all-cause mortality following mRNA COVID-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study C Sindet-Pedersen, F Michalik, J Emanuel Strange, D Moelager Christensen, T Alexander Gerds, C Andersson, et al. (+7)
86 [GO] 2022―Oct―15 COVID-19 vaccination in the pediatric age and risk for myocarditis A Aimo, M Cantinotti, G Panichella, A Clerico
87 [GO] 2022―Oct―15 Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers D Terentes-Printzios, V Gardikioti, E Solomou, E Emmanouil, I Gourgouli, P Xydis, et al. (+8)
88 [GO] 2022―Oct―15 COVID-19 vaccine-induced myocarditis vs. immune checkpoint inhibitor-induced myocarditis - same but different? L Zornitzki, O Havakuk, Z Rozenbaum, D Viskin, A Arbel, S Banai, et al. (+2)
89 [GO] 2022―Oct―15 Cardiac MRI findings in COVID-19 vaccine-related myocarditis: pooled analysis of 435 patients P Samimisedeh, E Jafari Afshar, N Shafiabadi, H Rastad
90 [GO] 2022―Oct―15 Constructing custom-made radiotranscriptomic signatures from CT angiograms: an application in COVID-19 vascular inflammation C P Kotanidis, C Xie, M Siddique, K Burnham, H Lockstone, R Kotronias, et al. (+8)
91 [GO] 2022―Oct―15 Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction K Gryglewska, A Sakowicz, M Banach, M Maciejewski, A Bielecka-Dabrowa
92 [GO] 2022―Oct―15 Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure M Bergami, O Manfrini, E Cenko, M Dorobantu, I Demiri, O Fronea, et al. (+9)
93 [GO] 2022―Oct―15 Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study K Matli, N Chamoun, A Fares, V Zibara, S Al-Osta, R Nasrallah, et al. (+3)
94 [GO] 2022―Oct―15 Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 registry F Santoro, I Nunez Gil, E Vitale, J Perez-Villacastin, A Fernandez-Ortiz, N D Brunetti
95 [GO] 2022―Oct―15 No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers M Radvan, M Kamenik, L Koc, G Matejova, E Bartecku, J Horinkova, et al. (+2)
96 [GO] 2022―Oct―15 Impact of coronavirus disease 2019 on adult patients with congenital heart disease I Cardoso, T Branco, A Constante, J Viegas, A Grazina, B Teixeira, et al. (+6)
97 [GO] 2022―Oct―15 Effect of real-time remote-based cardiac rehabilitation on subjective satisfaction and objective performance during the coronavirus disease 2019 pandemic Y Fukuta, S Arizono, S Tanaka, T Kawaguchi, T Fuseya, N Tsugita, et al. (+3)
98 [GO] 2022―Oct―15 Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide M Sano, T Toyota, T Morimoto, T Okada, Y Sasaki, T Taniguchi, et al. (+8)
99 [GO] 2022―Oct―15 High sensitivity troponin I and newly/recently diagnosed coronavirus-19 disease patients presenting to the emergency department: values above and below the 99th percentile predict 28 day mortality R M Nowak, G Jacobsen, B Cook, S Linoj, M Moyer, D Lanfear
100 [GO] 2022―Oct―15 Cardiac dysrhythmias among coronavirus-19 recovered symptomatic patients D Shamia, G Tsaban, L Baham, Y Raviv, M Haim
101 [GO] 2022―Oct―15 The association of angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers with renal protection in patients with SARS-CoV-2 A D Douen, S T Tan, M S Sukoo-Pertab, C B Bowser, O B Busari, W S Siu, et al. (+8)
102 [GO] 2022―Oct―15 Atrial fibrillation incidence in SARS-CoV-2 infected patients: predictors and relationship with in-hospital mortality A Maloberti, C Giannattasio, P Rebora, G Occhino, N Ughi, S Fabbri, et al. (+9)
103 [GO] 2022―Oct―15 Mid- and long-term atrio-ventricular mechanics in children after recovery from asymptomatic or mildly symptomatic SARS-CoV-2 infection J Sabatino, D Sirico, C Di Chiara, P Pogacnik, A Di Candia, F Bonfante, et al. (+9)
104 [GO] 2022―Oct―15 Cardiac impairment in Long Covid 1-year post SARS-CoV-2 infection A Roca-Fernandez, M Wamil, A Telford, V Carapella, A Borlotti, D Monteiro, et al. (+9)
105 [GO] 2022―Oct―15 Prevalence of abnormalities on cardiac MRI in unselected patients after recovery from acute SARS-CoV-2 infection and correlation with markers of immunity and coagulation: the SETANTA study R Colleran, R J Byrne, A Cradock, D O Ciardha, S McKeogh, H Wilson, et al. (+8)
106 [GO] 2022―Oct―15 No deterioration in function or volumetric parameters in elite athletes after SARS-CoV-2 infections compared to non-infected athletes: results from the ELITE cohort J Van Hattum, S M Verwijs, J J N Daems, S M Boekholdt, M Groenink, R N Planken, et al. (+8)
107 [GO] 2022―Oct―15 SARS-CoV-2 is associated withabnormal biomarkers of oxidative stress,and endothelial function linked with cardiovascular dysfunction four months after the infection I Ikonomidis, A Kountouri, A Mitrakou, J Thymis, K Katogiannis, E Korakas, et al. (+9)
108 [GO] 2022―Oct―15 Association between cardiovascular comorbidities and hospital admission in SARS-CoV-2 patients A D Douen, S T Tan, W S Siu, R P Panetti, M S Sukoo-Pertab, C B Bowser, et al. (+5)
109 [GO] 2022―Oct―15 Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants L Fu, D Gilham, S Stotz, C Sarsons, B Rakai, L Tsujikawa, et al. (+5)
110 [GO] 2022―Oct―15 SARS-CoV-2 vaccination and myocarditis in a highly vaccinated New Zealand population C Greer, M Daly, R Troughton, P D Adamson
111 [GO] 2022―Oct―15 Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study A Camps-Vilaro, I R Degano, R Brugada, M Pinsach, R Elosua, R Ramos, et al. (+9)
112 [GO] 2022―Oct―15 Non-contrast cardiac magnetic resonance imaging after SARS-CoV2 infection or vaccination in asymptomatic adolescents: insights from the EnIGMA study R Parraga, C Real, I Garcia-Lunar, G Pizarro, J Sanchez-Gonzalez, R Diaz-Munoz, et al. (+9)
113 [GO] 2022―Oct―14 Ventricular-arterial coupling impairment in patients recovered from COVID-19 S Lampsas, E Oikonomou, N Souvaliotis, A Anastasiou, O Katsarou, A Marathonitis, et al. (+9)
114 [GO] 2022―Oct―14 The prognostic value of speckle tracking echocardiography in patients hospitalized with COVID-19 E Cwiek-Rebowska, J D Kasprzak, D Filipiak-Strzecka, E Szymczyk, K Wdowiak-Okrojek, P Wejner-Mik, et al. (+5)
115 [GO] 2022―Oct―14 Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19 M L Luchian, A Motoc, B Roosens, J Magne, H Chameleva, J Geers, et al. (+9)
116 [GO] 2022―Oct―14 Evaluation of myocardial work in patients recovered from the severe form of COVID-19 T L F Sousa, M J N N Alves, M D T Melo, A L P Albuquerque, J G Martins, L F B Botelho
117 [GO] 2022―Oct―14 Comparison of COVID-19 clinical course between LVAD recipients implanted before and during COVID-19 pandemic S Wisniowska-Smialek, P Rubis, I Gorkiewicz-Kot, G Wasilewski, M Kaleta, D Sobczyk, et al. (+3)
118 [GO] 2022―Oct―14 Long-term mayor adverse cardiovascular events after COVID-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry F Santoro, N Di Nunno, A Centola, R Cetera, V Le Rose, J Perez-Villacastin, et al. (+3)
119 [GO] 2022―Oct―14 Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry S Garcia-Zamora, J M Picco, A J Lepori, M I Galello, A K Saad, M Ayon, et al. (+9)
120 [GO] 2022―Oct―14 The impact of COVID-19 on right ventricular function in chronic kidney disease patients L Tapoi, C Ureche, A Diaconu, V Vasiliu, L Siriteanu, T Andrian, et al. (+9)
121 [GO] 2022―Oct―14 COVID-19 pandemic impact on heart failure epidemiology and outcomes in Poland. National database study M Zaleska-Kociecka, M Celinska-Spodar, K Podwojcic, M Maluchnik, D Walkiewicz, T Hryniewiecki, P Leszek
122 [GO] 2022―Oct―14 Impact of in-hospital medical management for COVID-19 pandemic on door-to-balloon time in patients with ST-elevation myocardial infarction A Takasaki, T Kurita, M Yanagisawa, A Ino, D Hiramatsu, A Ikmi, et al. (+9)
123 [GO] 2022―Oct―14 1-year mortality after myocardial injury in COVID-19 patients B F O Gomes, T M B Silva, G P Dutra, L S Peres, N D Camisao, I R R Menezes, et al. (+6)
124 [GO] 2022―Oct―14 Use of artificial intelligence for point-of-care echocardiographic assessment of left ventricular ejection fraction among COVID-19 patients Z Dadon, N Levi, A Orlev, D Belman, A Butnaru, M Glikson, et al. (+2)
125 [GO] 2022―Oct―14 Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial M Kleiner Shochat, J Mohsen, M Abu Rumi, E Hellou, M Abolil, C Singer, et al. (+4)
126 [GO] 2022―Oct―14 COVID-19 vaccination decrease the risk of Intensive Care Unit hospitalisation in heart failure patients even in the time of Omicron variant: population based study J Parenica, J Jarkovsky, K Benesova, J Hlasensky, M Miklikova, P Kala, et al. (+3)
127 [GO] 2022―Aug―19 European Heart Journal paper on COVID-19 scoops top award for London-based researcher Judith Ozkan
128 [GO] 2022―Jun―17 Placing the risk of myopericarditis following COVID-19 vaccination into perspective Giovanna Liuzzo, Carlo Patrono
129 [GO] 2022―Mar―14 European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long COVID Filippo Crea
130 [GO] 2022―Feb―18 Not only lungs: COVID-19 hits platelets as well Dario Bongiovanni, Melissa Klug, Marco Valgimigli, Isabell Bernlochner
131 [GO] 2022―Feb―08 The association between neutrophil to lymphocyte ratio and echocardiographic parameters in hospitalised adults with COVID-19 - a retrospective analysis R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan
132 [GO] 2022―Feb―08 Demographic analysis and clinical outcomes of COVID-19 and myocardial infarction from a tertiary care centre in south India R Kongara, RAMESH Sankaran, T R Muralidharan, P Manokar, S Sadhanandham, S Nagendra Boopathy, et al. (+3)
133 [GO] 2022―Feb―08 Palliative care for patients with cardiovascular disease and COVID-19 in a major referral hospital T Correa, A M S Simao, J V B Sobreira, F Yarshell, F B Anbar, R T De Carvalho
134 [GO] 2022―Feb―08 The association between transthoracic echocardiographic parameters and severity of COVID-19 in hospitalised adults - a retrospective analysis R Agarwal, G Priyonugroho, S Hertine, S H Wicaksono, P Almazini, D Zamroni, H S Muliawan
135 [GO] 2022―Feb―08 Symptomatology, prognosis and clinical findings of myocarditis as an adverse event of COVID-19 mRNA vaccine: a systematic review VIKASH Jaiswal, AKASH Jaiswal, NITYA Batra, D Mukherjee, R Ruchika, ANGELA Ishak, et al. (+4)
136 [GO] 2022―Feb―08 Impact of Covid-19 on cardiovascular clinics: are we ready for tele-medicine? M Mujtaba, FAISAL Khanzada, DANISH Qayyum, TAHIR Saghir, SHARF Buraro
137 [GO] 2022―Feb―08 Effectiveness of a home-based cardiovascular disease prevention program during the COVID-19 pandemic P Chockalingam, V Natarajan, T Sekar, A Rajaram, M M Yusuf, S Gunasekaran, et al. (+2)
138 [GO] 2022―Feb―08 Virtual medical research mentoring and collaboration: breaking the bounds of nationality during the COVID-19 pandemic J S K Chan, D H H Lau, E King, Y K L Shum, L Roever, T Liu, et al. (+9)
139 [GO] 2022―Feb―08 Impact of the anti-hypertensive diets virtual education towards knowledge, attitude, practice, and reduction of blood pressure during covid-19 pandemic A Andrianto, M Ardiana, A Yutha, B P D Khrisna, R A Nugraha, T S Putra, et al. (+5)
140 [GO] 2022―Feb―08 Clinical manifestation and impact on management of acute coronary syndrome during covid-19 pandemic, lessons learnt from a tertiary care T Subburaja, K A Sambasivam, R Radhika, P Sankara Thiagarajan
141 [GO] 2022―Feb―08 Impact of the COVID-19 pandemic on cardiology services in the second year at a South Asian cardiac centre F A Cader, M M Haq, S R Khan
142 [GO] 2022―Feb―08 Early impact of COVID-19 pandemic on heart transplant volumes in Asia and Oceania: results from the Global Observatory on Donation and Transplantation (GODT) Y Manla, N Bader, G Bajwa, L Gobolos, F Alsindi, I Hamour, et al. (+2)
143 [GO] 2022―Feb―08 Correlation of cardiac biomarkers with computed tomography severity score in COVID-19 patients R Rivera, L Cuenza, T Razon-Cuenza
144 [GO] 2022―Feb―08 Anticoagulation practices and venous thromboembolism in COVID-19 patients in a Philippine tertiary hospital M Ramos
145 [GO] 2022―Feb―08 Thromboembolic complication among COVID-19 patients in the intensive care unit (ICU): a single-centre study from a Malaysian perspective H Zulkifly, F Mansor, I Abdul Halim Zaki, K S Eng, L C Kiok, T Ravi, et al. (+3)
146 [GO] 2022―Feb―08 Efficacy and safety of fondaparinux versus unfractionated heparin in patients hospitalised with severe COVID-19 pneumonia and coagulopathy: a randomised, open-label clinical trial L H Adrian, S A Hutomo, A D S Negari
147 [GO] 2022―Feb―08 Prevalence and predictors for high blood pressure during covid-19 vaccination in Thailand S Patamatamkul
148 [GO] 2022―Feb―08 Evaluation of outcome of Coronavirus disease 2019 patients receiving RAAS inhibitors (OCRAS study): a prospective observational study of Bangladeshi hypertensive patients A B D Majumder, M T Rahman, A K M Islam, M Ullah, M K Zaman, M A Reza, et al. (+9)
149 [GO] 2022―Feb―08 Impact of SARS-CoV2 pandemic onto acute ST-elevation myocardial infarction care and patient outcomes in a large tertiary cardiac center D Yong, M A Sulong, M Sundarajoo, N Am Haris, M Y Low, K Kaniappan, A A Nuruddin
150 [GO] 2022―Feb―08 The role of STEMI integrated networking system based on tele-cardiology for reducing ischemic time and crossing wire time delayed during COVID 19 pandemic M Rizki Fadlan, S Anjarwani, M Saifur Rohman
151 [GO] 2022―Feb―08 A survey-based comparison of cardiovascular health risk behaviours in Indian men and women during the pandemic P Chockalingam, V Natarajan, T Sekar
152 [GO] 2021―Dec―31 Frequency and outcome of acute coronary syndrome during the Covid-19 pandemic R A Mousavi, C Wallmueller, P Stratil, G Pichler, F Piringer, G Delle Karth, A Schober
153 [GO] 2021―Dec―20 Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
154 [GO] 2021―Oct―25 Impact of COVID-19 on angioplasty service and outcome of patients treated for critical limb ischaemia A Rodway, C Giltinan, A Dehghan-Nayeri, A Santos, M Stafford, M B Whyte, et al. (+7)
155 [GO] 2021―Oct―21 Stroke mechanisms associated with coronavirus disease (COVID-19) M Kruchinina, A A Gromov, V M Generalov, A V Rabko, V N Kruchinin
156 [GO] 2021―Oct―21 Echocardiogram in critically ill patients with COVID-19 B F O Gomes, T M B Silva, I R R Menezes, A S Azevedo, L S Peres, D F P Pereira, et al. (+9)
157 [GO] 2021―Oct―21 Impact of high cardiovascular risk on hospital mortality in patients admitted to intensive care by COVID-19 B F O Gomes, T M B Silva, G P Dutra, A S Azevedo, D F P Pereira, L S Peres, et al. (+5)
158 [GO] 2021―Oct―21 COVID-19 infection impact on cardiovascular and thrombotic events during acute phase and medium-term of the disease A Varela Lopez, L Diaz Argueso, C Broco Fernandez, C E Cacho Antonio, P J Antunez Muinos, O Otero Garcia, et al. (+9)
159 [GO] 2021―Oct―21 Introduction of alternative rehabilitation method for the patients with cardiovascular diseases in conditions of the COVID-19 pandemic R V Nesterak, I P Vakaliuk, N V Yakymchyk, I Drapchak, N V Savchuk, V I Sovtus, et al. (+2)
160 [GO] 2021―Oct―21 Cardiovascular evaluation with exercise testing using face mask during the COVID-19 pandemic H Ilarraza-Lomeli, J Rojano-Castillo, G Carazo-Vargas, P S Flores-Carrillo, C F Barrera-Ramirez, M D Rius-Suarez, H N Ortega-Aranda
161 [GO] 2021―Oct―21 The direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy D J Hammersley, R J Buchan, L Mach, R E Jones, B P Halliday, S K Prasad, et al. (+2)
162 [GO] 2021―Oct―21 Impact of COVID-19 pandemic on surgical care of patients with acute aortic conditions X Yuan, U Rosendahl, G Asimakopoulos, C Quarto, B Rosser, J Gaer, et al. (+4)
163 [GO] 2021―Oct―21 Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up V De Marzo, P Clavario, R Lotti, C Barbara, A Porcile, G Guglielmi, et al. (+6)
164 [GO] 2021―Oct―21 Clinical outcomes in COVID-19 patients with in-hospital cardiac arrest - an insight from multi-centre data M Mughal, I Kaur, S Waxman, H Gandhi, M Kakadia, Z Khakwani, et al. (+9)
165 [GO] 2021―Oct―21 Are there any long-term cardio-pulmonary limitations of hospitalized Covid-19 patients? R Badr Eslam, C Binder-Rodriguez, A Iscel, J Niebauer, R A Mousavi, C Kronberger, et al. (+2)
166 [GO] 2021―Oct―21 Comparison of echocardiographic parameters of patients with COVID-19 pneumonia in hospital and three months after discharge E Yaroslavskaya, D Krinochkin, N Shirokov, E Gultyaeva, V Garanina, A Mamarina, et al. (+4)
167 [GO] 2021―Oct―21 Critical COVID-19 rarely associated with left ventricular systolic impairment E Nakou, R Fisher, C Tountas, E Corcoran, A Dhariwal, A Marvaki, et al. (+9)
168 [GO] 2021―Oct―21 Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: in the grasp of SARS-CoV-2? B K Lakatos, M Tokodi, A Fabian, Z Ladanyi, Z Eles, V Juhasz, et al. (+9)
169 [GO] 2021―Oct―21 Impact of the first coronavirus-disease pandemic wave on cardiovascular admissions and sudden cardiac death rates in Greece E Pagourelias, V P Vassilikos, K Katsos, E Zaggelidou, N Raikos, S Tzikas, et al. (+9)
170 [GO] 2021―Oct―21 Myocardial injury in patients hospitalized for SARS-CoV19: a maker or a marker of prognosis? C Montalto, S Ghio, M Pagnesi, A Cappelletti, L Baldetti, E Baldi, et al. (+5)
171 [GO] 2021―Oct―21 Discriminatory accuracy of the SOFA score for determining clinical decompensation in patients presenting with COVID-19 N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, et al. (+5)
172 [GO] 2021―Oct―21 Prehospital period in patients with COVID-19 and community acquired pneumonia: age characteristics, cardiovascular comorbidity and pharmacotherapy during epidemic wave (the data of hospital registry) M Lukiyanov, S Y Martsevich, A A Pulin, N P Kutishenko, E Y Andreenko, V A Dindikova, et al. (+9)
173 [GO] 2021―Oct―21 Echocardiography and ECG monitoring not very beneficial in COVID-19 follow-up even in long haulers M Radvan, M Kamenik, L Koc, E Bartecku, L Sykorova, P Kala
174 [GO] 2021―Oct―21 Predictors of clinical decompensation in patients presenting with COVID-19 in an urban hospital health system N Krepostman, M Collins, K Merchant, S De Sirkar, L Chan, S Allen, et al. (+5)
175 [GO] 2021―Oct―21 COVID-19 in pregnant women with heart diseases. Adverse maternal and fetal outcomes. Case series from InCor registry of Pregnancy and Heart Disease M R Kirschbaum, M S Devido, E Azeka, L M M F Demarchi, J S Santos, D V R Pinto, et al. (+4)
176 [GO] 2021―Oct―21 Structure and predictors of repolarization disorders in patients with severe COVID-19 infection T D Danilevych, Y M Mostovoy, L V Rasputina
177 [GO] 2021―Oct―21 Closure of outpatient cardiac rehabilitation during the first COVID-19 lockdown in Austria in spring 2020 resulted in deteriorating physical exercise capacity: a mixed-methods study S T Kulnik, M Sareban, I Hoeppchen, S Droese, A Egger, J Gutenberg, et al. (+4)
178 [GO] 2021―Oct―21 Levels of hypersensitive troponin T in the emergency department as a predictive factor of mortality for hospitalized COVID-19 patients Y P Pionnier, P D Denoel, A M Manara, K Brousmiche
179 [GO] 2021―Oct―21 Assessment of vascular endothelial function in COVID-19 patients H Mejia-Renteria, A Travieso, A Sagir, E Martinez-Gomez, A Carrascosa-Granada, I Nunez-Gil, et al. (+3)
180 [GO] 2021―Oct―21 Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome M Scarpone, M Bergami, E Cenko, R Bugiardini, E Poluzzi, O Manfrini
181 [GO] 2021―Oct―21 Psychological profile of COVID-19 pneumonia survivors three month after hospitalization E Yaroslavskaya, O Guskova, B Prilenskii, T Petelina
182 [GO] 2021―Oct―21 Laboratory indicators of inflammation and systolic function of the left and right ventricles in patients with cardiovascular disease who have undergone COVID-19-associated pneumonia N Musikhina, T Petelina, E Yaroslavskaya, D Krinochkin, N Shirokov, N Osokina, E Gorbatenko
183 [GO] 2021―Oct―21 Obesity strongly predicts COVID-19-related major clinical adverse events in Coptic Clergy M Y Henein, I Bytyci, R Nicoll, S Rafik, S Ayad, F Vanchari
184 [GO] 2021―Oct―21 Interventional cardiology in times of COVID-19: impact on a terciary centre A Azul Freitas, C Ferreira, S Martinho, V Goncalves, J Almeida, J Rosa, et al. (+3)
185 [GO] 2021―Oct―21 Effect of body mass index on cardiac injury/cardiovascular outcomes in coronavirus disease 2019: a systematic review and meta-analysis M Ashraf, V Zlochiver, M S Rawala, M Dahar, J Robinson, M F Jan
186 [GO] 2021―Oct―21 Cardiac troponin as major mortality risk factor in SARS-CoV-2 infection A Gonzalez Leal, S Antonana Ugalde, A Arteagoitia Bolumburu, J M Monteagudo Ruiz, R R Martinez Moya, R Ortega Perez, et al. (+5)
187 [GO] 2021―Oct―21 SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players S Fikenzer, A Kogel, P Hepp, D Lavall, S T Stoebe, U Rudolph, et al. (+2)
188 [GO] 2021―Oct―21 The impact of anxiety level on medical decisions of non-COVID patients during the pandemic outbreak O Koren, S Abu Rajab, M Barbour, M Shachar, A Shahar, K Zubidat, et al. (+5)
189 [GO] 2021―Oct―20 Cardiac arrhythmias 3 months after hospitalization for COVID-19 C B Ingul, J Grimsmo, A Mecinaj, D Trebinjac, M Berger Nossen, S Andrup, et al. (+4)
190 [GO] 2021―Oct―20 Impact of the COVID-19 pandemic on emergent pacemaker implantation during lockdown and its aftermath D De Almeida Fernandes, R Cadete, J Guimaraes, E Monteiro, G Costa, N Antonio, L Goncalves
191 [GO] 2021―Oct―20 Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease H Barman, A Atici, H O Arabaci, I Sahin, B Gungor, S M Dogan
192 [GO] 2021―Oct―20 Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination Filippo Crea
193 [GO] 2021―Oct―20 Impact of COVID-19 in adult patients with congenital heart disease I Cardoso, T B Branco, A Constante, J Martins, L Sousa, J Viegas, et al. (+2)
194 [GO] 2021―Oct―20 The impact of the COVID-19 pandemic on the management and outcomes of STEMI patients in Switzerland S Fournier, T Mahendiran, D Radovanovic, G Pedrazzini, F Eberli, M Roffi, et al. (+2)
195 [GO] 2021―Oct―20 Comparison of D-dimer level measured on the third day of hospitalization with D-dimer level in predicting in-hospital mortality in COVID-19 patients M Selcuk, T Cinar, N Gunay, M Keskin, V Cicek, S Kilic, et al. (+2)
196 [GO] 2021―Oct―20 Modified CHA2DS2-VASc can predict mortality in COVID-19 patients admitted to the emergency department B V Silva, C Jorge, C Mendonca, M L Urbano, T Rodrigues, P Silverio Antonio, et al. (+9)
197 [GO] 2021―Oct―20 Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines R Ong, C Chacon, S Javier
198 [GO] 2021―Oct―20 Impact of type 2 diabetes mellitus on clinical outcomes in patients with COVID-19 and cardiovascular disease K G Lobanova, T Y U Demidova, V M Plakhotnyaya
199 [GO] 2021―Oct―20 Outcomes of COVID-19 infection in heart transplant recipients D Miklin, A Mantha, A Wolfson, A Vaidya, E Depasquale
200 [GO] 2021―Oct―20 Impact of COVID-19 lockdown on the procedural and intra-hospital outcome of STEMI patients L Gaede, H Rittger, H Gerrens, A Achajew, N Schacher, P Ferstl, et al. (+4)
201 [GO] 2021―Oct―20 Impact of COVID-19 on heart failure hospitalizations: one year after R Gonzalez-Manzanares, G Heredia Campos, C Fernandez-Aviles Irache, A Resua Collazo, C Pericet-Rodriguez, I Gallo-Fernandez, et al. (+9)
202 [GO] 2021―Oct―20 Prehospital ECG in patients with acute myocardial infarction during the COVID-19 pandemic M Avvedimento, A Leone, A Spinelli, A Franzone, G Esposito, R Piccolo
203 [GO] 2021―Oct―20 Impact of telehealth in the outpatient management of atrial fibrillation during the COVID-19 pandemic I Shatla, Y Sammour, K Kennedy, A P Wimmer
204 [GO] 2021―Oct―20 COVID-19 pandemic and admission rates for and management of acute coronary syndromes in Israel E Asher, A Fardman, D Zahger, K Orvin, M Mohsen, O Tsafrir, et al. (+9)
205 [GO] 2021―Oct―20 Indirect effects of COVID-19 Pandemic in ST-segment elevation myocardial infarction: insights from a multicentric national survey H Pereira, R Cale, P Farto-Abreu, E Pereira, S S L On Behalf Of Stent Save A Life Initiative
206 [GO] 2021―Oct―20 Effects of remote monitoring of patients with heart failure based on smartphone application in the context of the COVID-19 pandemic in the Kyrgyz Republic A R Rustambekova, M R Djusupbekova, A A Moldobaeva, A I Moldomamatova, A M Noruzbaeva
207 [GO] 2021―Oct―20 Impact of the Covid-19 pandemic on the device therapy for patients with the heart failure R Hall, R Chattopadhyay, P.J Pugh
208 [GO] 2021―Oct―20 In-hospital predictors of 60-day readmission in COVID-19 patients M Ruge, A Gill, J M D Gomez, J Du Fay De Lavallaz, J A Simmons, K A Williams, et al. (+4)
209 [GO] 2021―Oct―20 The impact of daily troponin-I and D-dimer serum levels on mortality of moderate-to-severe COVID-19 pneumonia patients B Stavileci, E Ozdemir
210 [GO] 2021―Oct―20 Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure M Selcuk, M Keskin, T Cinar, N Gunay, S Dogan, V Cicek, et al. (+5)
211 [GO] 2021―Oct―20 Three-month cardiac outcomes of survivors of COVID-19 presenting to a district general hospital in West Hertfordshire, UK P K Pyae, A Navarra, R Webb, A Newland-Smith, R Vancheeswaran, J Sehmi, A Barlow
212 [GO] 2021―Oct―20 Biochemical and cardiovascular predictors of PIMS risk in children after COVID-19 recovery =- the results of the LATE COVID Kids study I Jatczak-Pawlik, J Lewek, E Czkwianianc, K Zeman, P Jankowski, M Banach
213 [GO] 2021―Oct―20 Hypertension as a prognostic factor in the prediction of mortality in patients with COVID-19: a systematic review and meta-analysis C D P Pagdanganan, J Juangco
214 [GO] 2021―Oct―20 Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia F Fioretti, M Piazzani, D S Cani, A Madureri, G F Gensini, F Gabbrielli, et al. (+3)
215 [GO] 2021―Oct―20 Cardiovascular predictors associated with poor short-term prognosis in patients diagnosed with SARS-CoV-2 in Spain L Esteban-Lucia, A Devesa-Arbiol, M A Zambrano Chacon, A M Venegas Rodriguez, M Gonzalez-Rodriguez, L Maure-Blesa, et al. (+9)
216 [GO] 2021―Oct―20 The surgical management of heart failure: heart transplantation in the era of SARS-CoV-2 pandemic J Malyszek, M Jasinska, M Zembala, K Ratman, B Krol, K Tkocz, et al. (+4)
217 [GO] 2021―Oct―20 Sars-CoV2- infection as a trigger of humoral response against apolipoprotein A-1 S Pagano, S Yerly, N Suh, C Le Terrier, L Farrera-Soler, G Piumatti, et al. (+9)
218 [GO] 2021―Oct―20 Post-COVID myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19 O Blagova, D H Ainetdinova, Y U A Lutokhina, V M Novosadov, R S Rud', A Y U Zaitsev, et al. (+3)
219 [GO] 2021―Oct―20 Atrial fibrillation is associated with poor clinical trajectory of COVID-19 S.J Stjepan Jurisic, M.K Komminoth, B.W Wiggli, D.A.B Bertschi, P.K Koepfli, I.V Vranjic, et al. (+9)
220 [GO] 2021―Oct―20 Cardiovascular outcomes in hospitalized patients with COVID-19 and history of cancer: a CORONA-VTE analysis C D Khairani, B M Barns, S M Rizzo, M B Pfeferman, J E Snyder, S Z Goldhaber, G Piazza
221 [GO] 2021―Oct―20 Increased incidence of Persistent Pulmonary Hypertension of the Newborn following third trimester maternal COVID-19 infection A Ishqeir, A Nir, I Aptowitzer, M Godfrey
222 [GO] 2021―Oct―20 Blood pressure changes during the the COVID-19 pandemic and associated lockdown period N Girerd, C Meune, K Duarte, V Vercamer, M Lopez-Sublet, J J Mourad
223 [GO] 2021―Oct―20 Combined cardiac risk factors predict COVID-19 related mortality and the need for mechanical ventilation in Coptic Clergy M Y Henein, I Bytyci, R Nicoll, R Sheneuda, S Ayad, M Cameli, F Vancheri
224 [GO] 2021―Oct―20 Meta-Analysis of COVID-19 treatments on patients with a previous diagnosis of cardiovascular disease S Ben-Aicha, J Buchanan, M Moscarelli, P Punjabi, C Emanueli
225 [GO] 2021―Oct―19 Atrial fibrillation as a risk factor of severe course of COVID-19 A Mielczarek, J D Kasprzak, M Plewka
226 [GO] 2021―Oct―19 The correlation of anti-heart antibodies levels with clinical manifestations and outcomes in patients with COVID-19 O Blagova, N V Varionchik, V A Zaidenov, P O Savina, N D Sarkisova
227 [GO] 2021―Oct―19 Erythrocytes induce vascular dysfunction in COVID-19 A Mahdi, A Collado, J Tengbom, T Jiao, T Wodaje, J Yang, et al. (+3)
228 [GO] 2021―Oct―19 Clinical effects of the enhanced external counterpulsation therapy in patients with ischemic chronic heart failure exacerbation COVID-19 I Shashenkov, S.A Gabrusenko, S.L Babak, A.G Maliavin
229 [GO] 2021―Oct―19 Prognostic value of atrial fibrillation in COVID-19 admitted patients A Santos Sanchez, P E Gonzalez-Recio, E Sanchez-Corral, J J Jimenez-Nacher
230 [GO] 2021―Oct―19 Frontal QRS/T angle can predict mortality in COVID-19 patients R Gunduz, B S Yildiz
231 [GO] 2021―Oct―19 Changes in health perception of COVID-19 among patients with aortic diseases: a longitudinal study between the first and second wave of the COVID-19 pandemic A Parys, S Klinge, A Doenmez, C Rammos, T Rassaf, A Janosi, J Lortz
232 [GO] 2021―Oct―19 Prospective analysis of inflammatory response markers, endothelial dysfunction and hemostasis parameters in COVID-19 associated pneumonia patients with and without type 2 diabetes mellitus T Petelina, N Musikhina, K Avdeeva, S Leonovich, L Gapon, E Gorbatenko, et al. (+6)
233 [GO] 2021―Oct―19 Acute myocardial infarction in the Covid-19 era: incidence, clinical characteristics and in-hospital outcomes - a multicenter registry A Fardman, D Zahger, K Orvin, N Kofman, J Mohsen, O Tsafrir, et al. (+9)
234 [GO] 2021―Oct―19 Cardiac implantable electronic devices: a marker for poor outcome in patients with COVID-19 infection B Wizman, M Haim, N Yasoor, I Peles, V Novack, Y Konstantino
235 [GO] 2021―Oct―19 Arrhythmia patterns in patients with COVID-19 infection during and post hospitalization detected via a patch-based mobile cardiac telemetry system O Reynbakh, E D Braunstein, M Hsu, J Ellis, L Crosson, J Lenane, et al. (+3)
236 [GO] 2021―Oct―19 Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia P Jirak, Z Shomanova, R Larbig, D Dankl, N Frank, C Seelmaier, et al. (+9)
237 [GO] 2021―Oct―19 The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks D Trabattoni, G Teruzzi, P M Ravagnani, G Santagostino Baldi, P Montorsi, G Calligaris, et al. (+2)
238 [GO] 2021―Oct―19 Stent-Save a Life international survey on the practice of primary coronary angioplasty during the COVID-19 pandemic H Pereira, S S L On Behalf Of Stent Save A Life Initative
239 [GO] 2021―Oct―19 STEMI patients in the first and second wave of COVID-19 pandemic in Slovenia A Sinkovic, M Krasevec, J Golub, D Suran, M Marinsek, A Markota
240 [GO] 2021―Oct―19 Feasibility of remote support for electrophysiological ablation procedures during CoVid-19 pandemics A Muessigbrodt, F Demoniere, S Finoly, M Mommarche, J Inamo
241 [GO] 2021―Oct―19 Dynamics of myocardial global longitudinal strain in patients with COVID-19 without significant baseline cardiovascular pathology S Iakovlev, O Dukhin, E Ryzhkova, E Andreeva, A Kalinskaya
242 [GO] 2021―Oct―19 Clinical and morphological characteristics of COVID-19-associated myocarditis E A Kogan, A D Kukleva, O V Blagova, Y U S Berezovskij
243 [GO] 2021―Oct―19 Cardiac arrest in patients hospitalized for COVID-19: a tertiary medical center retrospective cohort study S Luo, J M Du-Fay-De-Lavallaz, J M D Gomez, S Fugar, L Golemi, C J Chiang, et al. (+5)
244 [GO] 2021―Oct―19 Expressing a truncated SARS-COV-2 spike protein in mouse heart induces cardiac hypertrophy S Negron, C Kessinger, Z Lin
245 [GO] 2021―Oct―19 Novel SARS-CoV-2 variants induce higher toxicity in cardiovascular cells J U G Wagner, D Bojkova, M Shumliakivska, G S Aslan, J D Kandler, A Hansen, et al. (+5)
246 [GO] 2021―Oct―18 Cardiac function is normal in most patients recovered from COVID-19 J Tangen, P Aukrust, A Barrat-Due, M Troseid, I Christoffer Olsen, K Nezvalova-Henriksen, et al. (+9)
247 [GO] 2021―Oct―18 Mid-term endothelial dysfunction post COVID-19 S Lampsas, E Oikonomou, G Siasos, N Souvaliotis, A Goliopoulou, C V Mistakidi, et al. (+6)
248 [GO] 2021―Oct―18 The role of cardiovascular calcifications in COVID-19 M Toselli, A C Cereda, F G Giannini, A S Scoccia, G G Gallone, A P Palmisano, et al. (+2)
249 [GO] 2021―Oct―18 Clinical and echocardiographic risk score predicts need for hospitalization among patients with COVID-19 J Kothari, K Shah, T Daly, P Saraiya, I Taha, M Le, et al. (+2)
250 [GO] 2021―Oct―18 Long-term post-discharge coagulation abnormalities in patients with moderate to severe COVID-19 G Artemyeva, A Kalinskaya, O Dukhin, A Lebedeva, A Rozin, A Shpektor, E Vasilieva
251 [GO] 2021―Oct―18 The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19 C Lee, N Patel, L Panepinto, M Byers, M Ambrosino, S Adusumalli, et al. (+3)
252 [GO] 2021―Oct―18 Cardiac involvement in patients recovered from coronavirus disease-2019 (COVID-19): a systematic review N Shafiabadi, H Rastad, M Mozafarybazargany, H Talakoob, H Karim
253 [GO] 2021―Oct―18 Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms M P Cassar, A J Lewandowski, M Mahmod, C Xie, E M Tunnicliffe, N Petousi, et al. (+4)
254 [GO] 2021―Oct―18 Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin C K Kaufmann, A A Ahmed, M K Kassem, M F Freynhofer, B J Jaeger, G A Aicher, et al. (+8)
255 [GO] 2021―Oct―18 Impact of COVID-19 disease on platelet reactivity and association with inflammatory parameters M Ascencio, M Munoz-Esquerre, Y Pascual, M Iglesias, J Sabater, O Murillo, et al. (+5)
256 [GO] 2021―Oct―18 Echocardiographic markers of mortality at 60 days in patients with COVID-19 in the intensive care unit J Sprockel, J M Rincon, M Rondon, M Bejarano, N Castellanos, Z Santofimio, et al. (+4)
257 [GO] 2021―Oct―18 Is endothelial dysfunction a driving force of COVID-19 induced coagulopathy? O Dukhin, A Kalinskaya, I Molodtsov, A Maltseva, D Sokorev, A Elizarova, et al. (+8)
258 [GO] 2021―Oct―18 Consequences on the right ventricular to pulmonary circulation coupling of COVID-19 infection A M Vella, F Bursi, G Santangelo, A Barbieri, F Toriello, F Valli, et al. (+3)
259 [GO] 2021―Oct―18 Clinical impact on treatment and prognosis of advanced cardiac imaging with echocardiography in the acute setting of a COVID-19 infection M Gonzalez Del Hoyo, L Servato, R Fernandez-Galera, E Rodenas, M Garcia, G Casas, et al. (+9)
260 [GO] 2021―Oct―18 Stress myocardial blood flow reduced after severe COVID-19, not related to symptoms P Doeblin, C Goetze, S Al-Tabatabaee, A Berger, F Steinbeis, M Witzenrath, et al. (+7)
261 [GO] 2021―Oct―18 Prognostic value of coronary artery calcium score in hospitalized COVID-19 patients A Motoc, M L Luchian, S Lochy, D Belsack, J Magne, B Roosens, et al. (+9)
262 [GO] 2021―Oct―18 Pocket-size ultrasound devices may improve the prompt assessment of Covid-19 patients D Filipiak, J D Kasprzak, P Lipiec
263 [GO] 2021―Oct―18 Preponderance of right ventricular dysfunction in COVID-19 patients with inflammatory heart disease S T Thodeti, D S L Lattanzio, T M K Kuraan, M U K Khalid, D D Drenic, R S R Raghupathy, et al. (+2)
264 [GO] 2021―Oct―18 Initial COVID-19 symptoms are not predictive of post-COVID recovery inflammatory heart disease detected by cardiac MRI S T Thodeti, D S L Lattanzio, D D Drenic, T M K Kuraan, M U K Khalid, S V V Vallabhaneni, J R M Mikolich
265 [GO] 2021―Oct―18 Association between cardiac pathology and outcomes of patients with COVID-19 using a hand-held ultrasound Z Dadon, N Levi, A Orlev, D Belman, E A Alpert, Y Steinmetz, et al. (+4)
266 [GO] 2021―Oct―18 Early microvascular modifications in patients previously hospitalized for COVID-19: comparison with healthy individuals P Malerba, C Agabiti Rosei, M Nardin, A Gaggero, G Chiarini, C Rossini, et al. (+6)
267 [GO] 2021―Oct―18 Cytokine storm induced coagulopathy in septic shock and critical Covid-19: head-to-head comparison M D M Dechamps, J De Poortere, P F Laterre, M Octave, A Ginion, V Robaux, et al. (+9)
268 [GO] 2021―Oct―18 Can echocardiographic parameters predict mortality in COVID-19? A Babu, N Eden, Z Meng, D Lamb, R Bhatia, V Voon
269 [GO] 2021―Oct―18 Echocardiographic parameters as predictors of three-months mortality in patients with 2019 Coronavirus infection T Miranda Aquino, J M Pereira-Forcado, B Ordonez-Salazar, G Dominguez-Trejo, A Rangel-Guerra, J Martinez-Castillo, et al. (+6)
270 [GO] 2021―Oct―18 Clinical characteristics and in-hospital outcomes of patients coinfected with Chagas disease and SARS-CoV-2 M Marcolino, I Molina, M C Pires, L E F Ramos, R T Silva, M H Guimaraes Junior, et al. (+9)
271 [GO] 2021―Oct―18 The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling E Avolio, M Carrabba, M Kavanagh Williamson, R Milligan, K Gupta, M Gamez, et al. (+6)
272 [GO] 2021―Sep―23 Transforming community cardiology practice to virtual visits: innovation at Cleveland Clinic during the COVID-19 pandemic Gautam V Shah, Ankur Kalra, Umesh N Khot
273 [GO] 2021―Aug―11 The 2020 Olympic/Paralympic Games and Covid-19 in Japan Hiroaki Shimokawa
274 [GO] 2021―Aug―06 Can the US COVID-19 Response Advance Equity in Cardiovascular Health? Erica S Spatz, Adam L Beckman, Oyere K Onuma, Elias Mossialos
275 [GO] 2021―Jun―28 Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre Mattia Lunardi, Darren Mylotte, William Wijns, Yoshinobu Onuma, Osama Soliman, Patrick W Serruys, Faisal Sharif
276 [GO] 2021―May―29 COVID-19 and the heart: insights from the National Societies of Cardiology Journals Jean-Jacques Monsuez
277 [GO] 2021―May―13 Cardio Egypt 2021: one of the first physical meetings in the era of Covid-19 Magdy Abdelhamid, Mohamed Osama, Khaled Shokry
278 [GO] 2021―May―08 The ongoing impact of COVID-19 on cardiovascular care Mark Nicholls
279 [GO] 2021―Apr―16 Old and new enemies: psychological stress, occupational stress, COVID-19, and a glimpse of the future Filippo Crea
280 [GO] 2021―Apr―07 Erratum to: Conducting Clinical Trials in Heart Failure During (and After) the COVID-19 Pandemic: An Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
281 [GO] 2021―Apr―06 Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19 Ulf Landmesser, Irina Lehmann, Roland Eils
282 [GO] 2021―Mar―26 COVID-19 and Emissions: An Opportunity for Sustainable Global Health Sanjay Rajagopalan, Robert B Jackson, Jagat Narula
283 [GO] 2021―Mar―26 C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target? Mark B Pepys
284 [GO] 2021―Feb―05 Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic Filippo Crea
285 [GO] 2021―Feb―04 Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences Eloi Marijon, Nicole Karam, Xavier Jouven
286 [GO] 2020―Dec―10 Innovation in transforming a large-scale scientific medical conference in China entirely online in response to COVID-19 Jianping Li, Yuxi Li, Yong Huo
287 [GO] 2020―Nov―29 Rheumatic heart disease and COVID-19 Andrea Beaton, Liesl Zühlke, Jeremiah Mwangi, Kathryn A Taubert
288 [GO] 2020―Nov―28 Response to COVID-19 in a large academic Centre in South Africa Ntobeko A B Ntusi
289 [GO] 2020―Oct―30 COVID-19 pandemic: a sentiment analysis Ashish Kumar, Safi U Khan, Ankur Kalra
290 [GO] 2020―Oct―16 The effects of COVID-19 on general cardiology in Italy Carmen Anna Maria Spaccarotella, Salvatore De Rosa, Ciro Indolfi
291 [GO] 2020―Oct―12 The stethoscope: a potential vector for COVID-19? Rajiv S Vasudevan, Khalid Bin Thani, Dhuha Aljawder, Samantha Maisel, Alan S Maisel
292 [GO] 2020―Sep―18 Virtual medical education during the COVID-19 pandemic: how to make it work Amr Idris, Basel Edris
293 [GO] 2020―Sep―07 Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient Eva Toth, Luke Dancy, George Amin-Youssef, Alexandros Papachristidis, Rafal Dworakowski
294 [GO] 2020―Sep―03 Understanding COVID-19: in the end it is the endothelium-what else? Thomas F Lüscher
295 [GO] 2020―Jul―22 COVID-19 and cardiovascular disease Mark Nicholls
296 [GO] 2020―Jul―08 Acute coronary syndromes in developing countries during the COVID-19 pandemic Karim Said, Yasser El-Baghdady, Mohamed Abdel-Ghany
297 [GO] 2020―Jul―05 COVID-19 testing Roberto Ferrari, Marco De Angelis
298 [GO] 2020―Jun―20 Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation Dan Hu, Kan Liu, Bixi Li, Zhenhong Hu
299 [GO] 2020―Jun―17 EHRA 2020 during COVID-19 days Haran Burri, Katja Zeppenfeld, Hein Heidbuchel
300 [GO] 2020―Jun―17 Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic? Alan G Fraser, Piotr Szymański, Elizabeth Macintyre, Martin Landray
301 [GO] 2020―Jun―15 COVID-19 pandemic in India Venkata S Ram, Giridhara R Babu, Dorairaj Prabhakaran
302 [GO] 2020―Jun―14 COVID-19 and Katrina: recalcitrant racial disparities Harriette G C Van Spall, Clyde W Yancy, Keith C Ferdinand
303 [GO] 2020―Jun―08 The saga continues: is COVID-19 a cardiopulmonary disease? Thomas F Lüscher
304 [GO] 2020―Jun―06 COVID-19 and the healthcare workers Ankur Kalra, Erin D Michos, Kavitha M Chinnaiyan
305 [GO] 2020―Jun―03 Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs Luis M Ruilope, Juan Tamargo, Gema Ruiz-Hurtado
306 [GO] 2020―May―28 Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations Petr Widimsky, Jiri Benes, Alexander M Celko
307 [GO] 2020―May―25 Acute coronary syndromes during COVID-19 Serafina Valente, Francesca Anselmi, Matteo Cameli
308 [GO] 2020―May―25 Myocardial injury in severe COVID-19 infection Allan S Jaffe, John G F Cleland, Hugo A Katus
309 [GO] 2020―May―20 The ‘Black Death’ and the physician at the time of COVID-19 Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari
310 [GO] 2020―May―16 COVID-19: (mis)managing an announced Black Swan Thomas F Lüscher
311 [GO] 2020―May―14 Changes in the work mode of cardiologists during the COVID-19 epidemic in Wuhan Xiang Cheng, Changsheng Ma, Yaling Han
312 [GO] 2020―May―08 COVID-19 and congenital heart disease in perspective Michael A Gatzoulis
313 [GO] 2020―May―08 SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome Jorge Solano-López, Angel Sánchez-Recalde, José Luis Zamorano
314 [GO] 2020―May―07 TeleCheck-AF for COVID-19 Dominik Linz, Nikki A H A Pluymaekers, Jeroen M Hendriks
315 [GO] 2020―May―07 What COVID-19 is taking away from us Massimo Mapelli
316 [GO] 2020―May―07 Trying times for heart failure trials during the COVID-19 pandemic Judy Ozkan
317 [GO] 2020―May―07 The Certificate of Advanced Studies (CAS) course adapted to a pandemic Francesco Maisano, Agnes Bäker, Maurizio Taramasso, Barbara Jenny, Luca Vicentini, Victoria Jenkins, et al. (+4)
318 [GO] 2020―May―06 Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19 Gavin Y Oudit, Marc A Pfeffer
319 [GO] 2020―May―06 Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy Riccardo M Inciardi, Marianna Adamo, Laura Lupi, Dario S Cani, Mattia Di Pasquale, Daniela Tomasoni, et al. (+16)
320 [GO] 2020―May―06 EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic Alaide Chieffo, Giulio G Stefanini, Susanna Price, Emanuele Barbato, Giuseppe Tarantini, Nicole Karam, et al. (+14)
321 [GO] 2020―May―06 Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 Shaobo Shi, Mu Qin, Yuli Cai, Tao Liu, Bo Shen, Fan Yang, et al. (+7)
322 [GO] 2020―Apr―30 The battle against COVID-19: mortality in Italy Roberto Ferrari, Aldo P Maggioni, Luigi Tavazzi, Claudio Rapezzi
323 [GO] 2020―Apr―28 Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients? Ruihai Zhou
324 [GO] 2020―Apr―27 A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience Yaling Han
325 [GO] 2020―Apr―22 Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective Paul Carter, Michael Anderson, Elias Mossialos
326 [GO] 2020―Apr―18 Fulminant myocarditis in the time of coronavirus Vittoria Cuomo, Roberta Esposito, Ciro Santoro
327 [GO] 2020―Apr―15 Key words to be adopted for COVID-19 research Aldo Maggioni, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari
328 [GO] 2020―Apr―13 Call to action for the cardiovascular side of COVID-19 Costanza Emanueli, Lina Badimon, Fabio Martelli, Ines Potočnjak, Irina Carpusca, Emma L Robinson, Yvan Devaux
329 [GO] 2020―Apr―13 Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis Thadathilankal-Jess John, Karim Hassan, Hellmuth Weich
330 [GO] 2020―Apr―13 Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts Luka Nicin, Wesley Tyler Abplanalp, Hannah Mellentin, Badder Kattih, Lukas Tombor, David John, et al. (+8)
331 [GO] 2020―Apr―08 CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic Marijke Linschoten and, Folkert W Asselbergs
332 [GO] 2020―Apr―08 Priorities for Cath labs in the COVID-19 tsunami Gianluca Campo, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari
333 [GO] 2020―Apr―08 Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage Bernhard Metzler, Peter Siostrzonek, Ronald K Binder, Axel Bauer, Sebastian Johannes Reinstadler
334 [GO] 2020―Apr―07 Transient complete heart block in a patient with critical COVID-19 Mona Azarkish, Vahideh Laleh far, Masoud Eslami, Reza Mollazadeh
335 [GO] 2020―Apr―07 Strategies to control COVID-19 and future pandemics in Africa and around the globe Anouar Fanidi, Xavier Jouven, Bamba Gaye
336 [GO] 2020―Apr―07 COVID-19 experience in Bergamo, Italy Michele Senni
337 [GO] 2020―Apr―07 Denominator matters in estimating COVID-19 mortality rates Bamba Gaye, Anouar Fanidi, Xavier Jouven
338 [GO] 2020―Apr―07 Typical takotsubo syndrome triggered by SARS-CoV-2 infection Philippe Meyer, Sophie Degrauwe, Christian Van Delden, Jelena-Rima Ghadri, Christian Templin
339 [GO] 2020―Apr―03 COVID-19-related myocarditis in a 21-year-old female patient In-Cheol Kim, Jin Young Kim, Hyun Ah Kim, Seongwook Han
340 [GO] 2020―Apr―01 The Cardiologist at the time of Coronavirus: a perfect storm Claudio Rapezzi, Roberto Ferrari
341 [GO] 2020―Mar―31 Initial COVID-19 affecting cardiac patients in China Yaling Han
342 [GO] 2020―Mar―30 Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by ‘on the scene’ cardiologists Lin Zhang, Yongzhen Fan, Zhibing Lu
343 [GO] 2020―Mar―25 Acute pulmonary embolism and COVID-19 pneumonia: a random association? Gian Battista Danzi, Marco Loffi, Gianluca Galeazzi, Elisa Gherbesi
344 [GO] 2020―Mar―24 Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 Alina Hua, Kevin O’Gallagher, Daniel Sado, Jonathan Byrne
345 [GO] 2020―Mar―19 SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Gabriela M Kuster, Otmar Pfister, Thilo Burkard, Qian Zhou, Raphael Twerenbold, Philip Haaf, et al. (+2)
346 [GO] 2020―Mar―13 Coronaviruses and the cardiovascular system: acute and long-term implications Tian-Yuan Xiong, Simon Redwood, Bernard Prendergast, Mao Chen
347 [GO] 2020―Mar―06 Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin Hongde Hu, Fenglian Ma, Xin Wei, Yuan Fang
 [1] 

347 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.117 sec